Search
Life Sciences Regulatory Overview In this episode, we explore the complex regulatory landscape of the life sciences industry, providing attorneys with critical insights into the compliance requirements that govern pharmaceuticals, medical devices, and diagnostics. Whether you advise biotech startups...
Life Sciences Industry Basics This episode provides attorneys with a comprehensive foundation in the life sciences industry, equipping legal professionals with the knowledge needed to navigate this complex and highly regulated sector. Whether you advise pharmaceutical companies, biotech startups, or...
Saul Ewing's Intellectual Property attorneys hosted a half-day virtual conference that addressed the following trends and challenges affecting businesses and innovators nationwide: Learning how to combat brand impersonation and cyber fraud with legal tools, cybersecurity measures, and cross-industry...
With fall sports in full swing, it may be easy to miss the fact that the NCAA has also been busy competing in the courtroom. On the same day that a federal judge in California preliminarily approved a $2.78 billion settlement permitting college athletes to apply for payment for their on-field...
PCI, in partnership with Penn Medicine, is pleased to co-host a commercialization speaker series geared toward Penn Medicine faculty, researchers and students. Each session will feature an expert guest speaker as well as time for questions and discussion. The first session will discuss the latest...
Trending Risk Management Topics in Athletics Tuesday, September 12 1:45 pm - 2:45 pm EDT ABOUT Athletics at colleges and universities offer students the ability to build skills including physical fitness, teamwork, and perseverance. Athletics also create risk, and with athletic risks evolving and...
Charles M. Lizza and Sarah A. Sullivan of Saul Ewing’s Newark Office secured a precedent-setting victory in a patent infringement case in the Federal District Court for the District of New Jersey involving Janssen Pharmaceuticals, Inc.’s (“J&J”) and Mitsubishi Tanabe Pharma Corp.’s (“MTPC”)...